As a premier global event in laboratory medicine, the 2026 ADLM Expo in the United States brings together cutting-edge IVD technologies and premium resources. B&E made a major impression with four proprietary core products, showcasing the R&D prowess of Chinese IVD companies and the power of national medical innovation through hardcore technological breakthroughs.
The i-Check200 Handheld Blood Gas Analyzer, benchmarked against international standards set by Abbott and Siemens, is a rare high-end portable blood gas testing device globally. With nearly 1,000 units installed worldwide within three years of launch, it is suitable for a full range of point-of-care scenarios including intensive care, emergency, pre-hospital transport, and outdoor first aid. Its stable performance and strong practicality have earned widespread acclaim in global markets.
The BC200 Biochemical Analyzer incorporates the company's exclusive maintenance-free integrated biosensor core technology, breaking through traditional equipment bottlenecks to deliver a differentiated all-in-one testing solution. Leveraging its unique technical advantages, it offers a fresh approach to global biochemical testing innovation.
The G80 HbA1c Analyzer adopts the Gold-standard HPLC method, processing 60 samples per hour. Its high throughput and precision place it among the top performers in its class worldwide, fully adaptable to medical institutions at all levels and providing reliable support for refined diabetes care globally.
The Hemax60 Hematology Analyzer embodies the philosophy of "compact size, high performance." Its small footprint makes it ideal for small-to-medium laboratories and space-constrained testing environments. The device delivers accurate detection of advanced parameters such as reticulocytes and nucleated red blood cells, pushing the performance limits of compact systems. Its exceptional cost-performance ratio has earned high recognition from international customers.
Through continuous technological innovation and deep industry expertise, B&E's full product portfolio now stands at the forefront of the international IVD sector, leading innovation trends and serving as a highly recognizable Chinese innovation icon at this year's ADLM Expo.
Building on its global footprint, the company continues to enhance localized service systems. Its U.S. subsidiary collaborates with premium local distributors to establish a mature reagent supply chain, creating a one-stop service ecosystem covering supply, parts, and after-sales support. This approach streamlines service links across the Americas market, efficiently meeting overseas clinical testing needs while steadily elevating the brand's global influence.
Empowering growth through innovation, and serving the world with craftsmanship. Looking ahead, B&E will continue to deepen R&D in core IVD technologies, accelerate its global strategic expansion, and drive the advancement of global laboratory medicine with high-quality products and comprehensive services—bringing Chinese medical innovation to the world and serving global healthcare!
